CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 500 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $464,000 | -12.1% | 3,812 | +10.6% | 0.12% | -16.3% |
| Q4 2020 | $528,000 | +54.4% | 3,447 | -15.7% | 0.15% | +38.7% |
| Q3 2020 | $342,000 | +6.2% | 4,087 | -6.6% | 0.11% | -1.9% |
| Q2 2020 | $322,000 | +51.2% | 4,377 | -13.0% | 0.11% | +22.7% |
| Q1 2020 | $213,000 | -28.8% | 5,033 | +2.4% | 0.09% | -14.6% |
| Q4 2019 | $299,000 | +19.6% | 4,913 | -19.3% | 0.10% | +10.8% |
| Q3 2019 | $250,000 | -16.4% | 6,088 | -4.2% | 0.09% | -16.2% |
| Q2 2019 | $299,000 | +31.7% | 6,354 | 0.0% | 0.11% | +32.1% |
| Q1 2019 | $227,000 | – | 6,354 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |